A team of international collaborators under Sydney Vital’s Flagship 2, has won the 2nd prize in the 2nd International-Atom Indonesia Best Paper Awards 2018 (I-AIBPA 2018)
Ms Grace Lim, the PhD student under our Thyroid Cancer TCE (Translational Centre of Excellence), was awarded a Sydney Vital Travel Grant to attend and present her research study at this year’s annual meeting of the American Thyroid Association.
On 5th November, Prof Alexander Engel ( committee member and director of Sydney Vital) gave a presentation of Sydney Vital at the Surgical Grand Rounds.
After introducing our current position and roles, Prof Engel summarised our achievements and outcomes over the past four years comprehensively and addressed Vital’s plan and vision for the upcoming years.
For access to the full presentation content, please click here.
Dr Sarah Hayes, one of our early career researchers who specializes in proteomics research, was awarded a Sydney Vital Travel Grant to attend the 17th Human Proteome Organisation (HUPO) World Congress (Sept 30 – Oct 3, 2018)
On the August 9, 2018, Sydney Vital teamed up with The Unicorn Foundation to host the 2018 Neuroendocrine Tumour Q&A Session. The session saw over 100 attendees come together to hear about what’s new in Neuroendocrine Tumours and why research plays a vital role in patient outcomes.
Sydney Vital is pleased to invite applications for its Seed Funding Awards to the value of $25,000 each. The Sydney Vital Seed Funding Scheme intends to seed new ideas, with the goal of generating data to a point where external funding may be sought. The ideas to be tested should be (i) new in concept and (ii) distinct from currently or previously funded research. Projects should focus on Translational Cancer Research and closely align with one or more of Sydney Vital’s Flagship Programs and/or Translational Cancer Research Centres (TCE) which are;
Breast Cancer Implementation
Sydney 1000 CRC
Call for Applications: 14 February 2018
Closing Date for Applications: 9th March 2018
Any queries should be directed to firstname.lastname@example.org
Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $10,000 each for one year, to students, preclinical and clinical researchers working in the area of Translational Cancer Research.
The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.
|1||Jerikho Bulanadi||Kolling Institute of Medical Research||Prof Ross Smith||Chemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery.||$15,000|
|2||Emma Colvill||Sydney University Medical School||Prof Paul Keall||The bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer||$15,000|
|3||Grace Gifford||Haematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, Sydney||Dr William Stevenson||Gene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making.||$15,000|
|4||Dr Anthony Glover||Kolling Institute of Medical Research, Royal North Shore Hospital||Prof Stanley Sidhu||Noncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes.||$15,000|
|5||Diana Hatoum||Faculty of Science, UTS Sydney||Dr Najah Nassif||A Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer.||$15,000|
|6||Samuel Brennan||Faculty of Science, UTS Sydney||Dr Rose Martiniello-Wilks||Development of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis.||$15,000|
|7||Ben Harris||Sydney Medical School, University of Sydney||Dr Kellie Charles||Investigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation.||$15,000|
|8||Adrian Lee||Bill Walsh Translation Cancer Research Laboratory, Kolling Institute||Dr Viive Howell||"Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with|
|9||Jaynish Shah||Sydney Medical School, University of Sydney||Prof Deborah Marsh||Investigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key?||$15,000|